SCHEMBL440980

SCHEMBL440980

CNP(=O)(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11995816 0.78
SCHEMBL11567734 0.78
Phosphoric Acid SCHEMBL379579 0.76 CA2 (0.50)
Phosphoric Acid SCHEMBL379580 0.76
Phosphoric Acid SCHEMBL25355235 0.76 CA2 (0.50)
SCHEMBL10931634 0.75
SCHEMBL1890005 0.75
Methyl Phosphonate SCHEMBL9815625 0.73 CA2 (0.73)
Phosphoric Acid SCHEMBL29086737 0.73
Phosphoric Acid SCHEMBL4326446 0.73 CA2 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 577 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11998601-B2 Messenger RNA therapy for treatment of articular disease TRANSLATE BIO, INC. (US) 2024-06-04 US claimed
WO-2024027767-A1 HERBICIDE COMPOSITION COMPRISING URACIL COMPOUND COMPRISING CARBOXYLATE FRAGMENT AND USE OF HERBICIDE COMPOSITION 江苏中旗科技股份有限公司 2024-02-08 WO claimed
EP-3846854-A2 IMPROVED POLYPEPTIDE COUPLED ANTIBIOTICS Mier, Walter (DE) 2021-07-14 EP claimed
EP-3329941-A1 RNA-CODED BISPECIFIC ANTIBODY CureVac AG (DE) 2018-06-06 EP claimed
EP-2101823-B1 RNA-CODED ANTIBODY CUREVAC AG (DE) 2016-11-23 EP claimed
EP-0824504-B1 IMPROVED DESTRUCTION OF ELECTRON AFFINIC CONTAMINANTS DURING WATER TREATMENT USING FREE RADICAL PROCESSES RES CORP TECHNOLOGIES INC (US) 1999-07-07 EP claimed
US-4582650-A NOBLE METAL DISPERSED IN SUPPORT &amp; ACTIVE CARBON CATALYST MONSANTO COMPANY (US) 1986-04-15 US claimed
US-20240209109-A1 TUMOR ANTIGEN-DEPENDENT CD40 AGONISTS ANTIBODIES Lepu Biopharma Co., Ltd. (CN) 2024-06-27 US disclosed
US-12016954-B2 CNS delivery of mRNA and uses thereof TRANSLATE BIO, INC. (US) 2024-06-25 US disclosed
WO-2024130241-A1 STABILIZED LIPID NANOPARTICLES FOR THE DELIVERY OF NUCLEIC ACIDS CASE WESTERN RESERVE UNIVERSITY (US) 2024-06-20 WO disclosed
WO-2024129964-A1 CHIMERIC ANTIGEN RECEPTORS INCLUDING JAK/STAT BINDING DOMAINS AND MODIFIED IMMUNE CELLS CARISMA THERAPEUTICS INC. (US) 2024-06-20 WO disclosed
EP-4384161-A1 INHIBITORS OF 12/15-LIPOXYGENASE The General Hospital Corporation (US) 2024-06-19 EP disclosed
EP-2858679-B2 PULMONARY DELIVERY OF MRNA TO NON-LUNG TARGET CELLS TRANSLATE BIO INC (US) 2024-06-05 EP disclosed
US-4582650-A NOBLE METAL DISPERSED IN SUPPORT &amp; ACTIVE CARBON CATALYST MONSANTO COMPANY (US) 1986-04-15 US disclosed
US-4501666-A CONTACTING WITH A PHOSPHOMETHYLAMINOCHELATE RESIN NIPPON MINING CO., LTD. (JP) 1985-02-26 US disclosed
US-4440924-A PRESENCE OF MAGNESIUM AND PHOSPHORUS COMPOUND TOYO BOSEKI KABUSHIKI KAISHA (JP) 1984-04-03 US disclosed
US-4410518-A N-Phosphinoaminosulfinylcarbamate esters and their use as insecticides REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1983-10-18 US disclosed
US-4352810-A ANTIODOTES FOR NERVE GASES Nederlandse Centrale Organisatie Voor Toegepast-Natuurwetenschappelijkond erzoek (NL) 1982-10-05 US disclosed
US-4290931-A IN PAINTS AND PAPER COATING HOECHST AKTIENGESELLSCHAFT (DE) 1981-09-22 US disclosed
US-4072706-A TO PRODUCE SECONDARY AMINES MONSANTO COMPANY (US) 1978-02-07 US disclosed